Effects of biologic drugs on the prognosis of rheumatoid arthritis among patients with poor diabetes control.
Yusuke MiwaYuko MitamuraPublished in: European journal of rheumatology (2020)
The bDMARD therapy reduced the RA disease activity regardless of a good or poor DM control.
Keyphrases
- rheumatoid arthritis
- disease activity
- ankylosing spondylitis
- rheumatoid arthritis patients
- systemic lupus erythematosus
- juvenile idiopathic arthritis
- type diabetes
- interstitial lung disease
- cardiovascular disease
- glycemic control
- metabolic syndrome
- mesenchymal stem cells
- skeletal muscle
- bone marrow
- idiopathic pulmonary fibrosis